Jan. 10 at 2:29 PM
$PCRX still scratching my head to the reaction of
$726.4mill revenue for 2025’. Per their last earnings release, where they lowered rev guidance, they projected
$725MIL at bottom end of range and they’re above that. Not sure why this was such a surprise. Analysts projected more ? No idea why many stock prices are dictated by analyst projections instead of growth rates and cash flows.. sooo stooopid.
